- Previous Close
82.30 - Open
75.30 - Bid 80.10 x --
- Ask 82.20 x --
- Day's Range
73.70 - 80.10 - 52 Week Range
62.35 - 99.64 - Volume
803 - Avg. Volume
897 - Market Cap (intraday)
239.523M - Beta (5Y Monthly) 0.05
- PE Ratio (TTM)
27.81 - EPS (TTM)
2.88 - Earnings Date Feb 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in Ahmedabad, India.
www.ishitadrugs.com17
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: ISHITADR.BO
View MorePerformance Overview: ISHITADR.BO
Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ISHITADR.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ISHITADR.BO
View MoreValuation Measures
Market Cap
246.10M
Enterprise Value
161.26M
Trailing P/E
28.58
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.65
Price/Book (mrq)
2.40
Enterprise Value/Revenue
1.08
Enterprise Value/EBITDA
12.84
Financial Highlights
Profitability and Income Statement
Profit Margin
5.77%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
149.3M
Net Income Avi to Common (ttm)
8.62M
Diluted EPS (ttm)
2.88
Balance Sheet and Cash Flow
Total Cash (mrq)
105.93M
Total Debt/Equity (mrq)
20.58%
Levered Free Cash Flow (ttm)
--